Healthcare -
Biotechnology - NASDAQ - US
$ 40.61
0.794 %
$ 2.63 B
Market Cap
-17.35
P/E
KYMR - STOCK-BASED COMPENSATION
Stock-based Compensation KYMR - Kymera Therapeutics, Inc.
43.1 M
LAST VALUE
31.40%
2 YEAR CAGR
131.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR